By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb
Symbol: BMY



PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech, Inc.  - Cancer

Gilead (Seattle, WA) 

Company News
Bristol-Myers Squibb (BMY) Soars After Halting Study Early As Opdivo Aces Test Again 4/17/2015 7:07:53 AM
Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY) 4/16/2015 11:21:53 AM
Lexicon Pharmaceuticals, Inc. (LXRX) And Bristol-Myers Squibb (BMY) Select Development Candidate For Neuropathic Pain In Neuroscience Drug Discovery And Development Alliance 4/15/2015 2:46:16 PM
Bristol-Myers Squibb (BMY) To Highlight SQI Diagnostics's Technology At WRIB Conference 4/9/2015 9:12:02 AM
Bristol-Myers Squibb (BMY) Completes Previously Announced Acquisition Of Flexus Biosciences 4/8/2015 11:07:19 AM
uniQure (QURE) Announces Webcast To Discuss Bristol-Myers Squibb (BMY) Collaboration 4/6/2015 9:56:44 AM
Flexus Biosciences Chemists Spin Off New Company After Bristol-Myers Squibb (BMY) $1.25 Billion Buyout 4/6/2015 6:12:16 AM
uniQure (QURE) Soars After Bristol-Myers Squibb (BMY) Bets $1 Billion on Gene Therapy Platform 4/6/2015 5:48:19 AM
Bristol-Myers Squibb (BMY) To Announce Results For First Quarter 2015 On April 28 3/27/2015 10:02:53 AM
European Regulators Postpone Bristol-Myers Squibb (BMY)’s Opdivo Decision Until April or Later, As Markets Wait Anxiously 3/27/2015 8:58:24 AM